There is limited evidence that lower C-peptide could be used to predict how soon insulin therapy may be required in those with T2D and one study suggesting it could be used to guide insulin dosage in those on an insulin pump [71]. The gene discussed is INS; the disease is type 2 diabetes mellitus.